INTRODUCTION
β-N-methylamino-L-alanine (L-BMAA) is routinely described in the literature as a neurotoxin, which is produced by most cyanobacteria (Lee and McGeer, 2012) . In the last few years L-BMAA has become relevant, because it has been related to several neurodegenerative diseases such as amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS-PDC), Alzheimer disease (AD) and ALS (Holtcamp, 2012) . Recent findings have demonstrated that glycogen synthase kinase-3 (GSK3) can play an important role in several disorders, AD in particular (Salcedo-Tello et al., 2011) . GSK3 exists as two isoforms, GSK3α and GSK3β, which are inactivated by phosphorylation of Ser 21 (GSK3α) and Ser 9 (GSK3β). This phosphorylation causes its inactivation and is the primary mechanism responsible for growth factor inhibition of this kinase (Sutherland et al., 1993) . Another important hallmark of neurodegenerative diseases is the formation of TAR DNA-binding protein 43 (TDP-43) pathological aggregates. Under normal conditions, TDP-43 is predominantly located in the nucleus, but in pathological conditions is translocated to the cytosol and form aggregates (Brettschneider et al., 2012) . It has been found that this protein is the major component of tau negative and ubiquitin-positive inclusions that characterize some neurodegenerative diseases (Lee et al., 2011) . Taking into account the role of GSK3β and TDP-43 as possible neurodegenerative disease hallmarks, the goal of this work is to know whether L-BMAA causes alterations in GSK3β and TDP-43 in neuroblastoma cells, in conditions under which L-BMAA produces neuronal death.
SY5Y cells. This cell line has been widely used as model of neurons, since these cells posses many biochemical and functional properties of neurons (Xie et al., 2010) . Cells treated with L-BMAA were resuspended in a icecold buffer (20 mM Tris-HCl, pH 7.5, 10 mM NaCl), with protease inhibitor cocktail and phosphatase inhibitor cocktail (Sigma-Aldrich). Lysated cells are considered as total extract. Nuclear and cytosolic fractions were obtained as described previously (Calcerrada et al., 2002) . Protein fraction (50 μg) was analyzed by SDS-PAGE on a 10% Tris-glycine gel. To examine the effect of L-BMAA on TDP-43, urea extraction was performed as previously described (Liu-Yesucevitz et al., 2010) . Urea-fraction (100 μg of protein) was analyzed by using gradient PAGE on a 4-16% in a Tris-glycine gel.
To immunodetection analysis, gel electrophoresis were transferred to nitrocellulose, and probed with rabbit polyclonal primary antibodies: anti-GSK3 α/β, anti-p-GSK3β(Ser9), anti-ubiquitin and anti-α-tubulin (Novus Biologicals, Littleton, CO, USA), anti-TDP-43 and anti-pS409/410 (ProteinTech Group, Chicago, IL, USA). Horseradish peroxidase-conjugated anti-rabbit IgG secondary antibody was purchased from ProteinTech Group. Digital images were acquired using a Fujifilm Intelligent Darkbox II (Fuji Systems USA, Stamford, CT, USA).
Statistical analysis
Results are presented as means ± S.D. in this article. The data from each biochemical experiment were analyzed separately and treated by ANOVA. Experiments were repeated three times with triplicate samples for each experiment. Student's t-test was also used to compare the samples. Values of p ≤ 0.05 were considered statistically significant.
RESULTS
To examine the action of L-BMAA on cell viability, SH-SY5Y cultures were treated with different amino acid concentrations for different times. Our results indicated that L-BMAA decreases cellular viability in a doseresponse manner, being the maximal effect about a 32% ( Fig. 1 ). Cell death was L-BMAA concentration dependent, increased with exposure time, resulting after 48 hr greater than 24 hr ( Fig. 1) .
Taking into account the important role of GSK3β in the neurodegenerative processes (Salcedo-Tello et al., 2011) , we analyzed the levels and the subcellular distribution of this enzyme after 10 mM L-BMAA treatment.
Results showed an increase in GSK3β levels concomitant with a p-GSK3β((Ser9) decrease in cellular total extracts after L-BMAA treatment, this fact would indicate that an enzyme activation takes place. When the nuclear fraction was analyzed, an increase in GSK3β was observed, with- Vol. 38 No. 3 out any change in the cytosol (Fig. 2) . In the same figure, it can be appreciated that an increase in nuclear GSK3α occurs. Although in recent years GSK3β has been the main isoform related with neurodegeneration, GSK3α has also been described to play a possible role in the pathological process such as ALS and AD (Chung et al., 2008; Azoulay-Alfaguter et al., 2011) . In order to determine whether L-BMAA treatment may result in altered forms of TDP-43, appearing frequently in neurodegenerative diseases forming pathological aggregates, high molecular weight, phosphorylated and truncated forms were analyzed. Our data indicated that the addition of L-BMAA caused an increase in insoluble TDP-43 and pS(409/410)TDP-43, together with the appearance of high molecular weight TDP-43 forms and insoluble 25 kD and 35 kD low molecular weight fragments of this protein (Figs. 3A and 3C) .Furthermore, the results also indicated that the addition of L-BMAA caused a high degree of protein ubiquitination (Fig. 3B) . It is noteworthy that the presence of ubiquitinated inclusions has been reported as a hallmark of most adult onset neuropathological disorders (Yamamoto and Simonsen, 2011) .
DISCUSSION
Since the discovery of amino acid L-BMAA as neurotoxin, a great deal has been learned about its mechanism of action. The main mechanism of neurotoxicity of L-BMAA has been reported to be a receptor agonist of glutamate (Ross et al., 1987; Chiu et al., 2012) . However, exactly how it causes neuronal death is not well understood. The finding that L-BMAA directly induces neu- ronal death supports the theory that this aminoacid may serve as the etiologic agent for ALS/PDC syndrome. Results obtained in this study indicate that L-BMAA causes neuronal death as observed by cellular viability evaluation. In the present study, the high concentration required inducing cell death may be due to immortalized cells undergo cell division, which could compensate for cell death. In this sense, high L-BMAA concentrations have been used by other authors in similar studies by using human neuroblastoma (Okle et al., 2013; McGeer, 2012). Taking into account the changes observed in both GSK3 and TDP-43 in some neurodegenerative processes, we have investigated whether treatment with the neurotoxic amino acid evokes alterations in both proteins, in experimental conditions where L-BMAA causes cell death. We have found an increase in nuclear GSK3β without a cytosol decrease. In this regard, we must point out that insults, that induce cell death can cause accumulation of GSK3β in the nucleus prior to the activation of the caspase cascade (Bijur and Jope, 2001 ). In addition, it has been described an increased level of GSK3β expression in frontal and temporal cortex in ALS with cognitive impairment (Yang et al., 2008) . This enzyme is involved in normal and pathological tau phosphorylation (Balaraman et al., 2006) and it can play a role in AD pathogenesis (Kremer et al., 2011) .
On the other hand, GSK3β has been established as an antiapoptotic regulator of death receptor-induced extrinsic apoptosis, but this protective action occurs when GSK3β is located in the cytosol (Beurel and Jope, 2006) . Under basal conditions, GSK3β is mostly cytosolic and associated with multiprotein complexes, which are their substrates (Meares and Jope, 2007) . After stimulation, GSK3β is released from protein anchors and is translocated to nucleus, where produces cell death (Bijur and Jope, 2001) . Moreover, it has been implicated in important cellular functions achieved by GSK3 phosphorylation of numerous transcription factors (Sakamaki et al., 2012) . The results described herein indicate that the toxicity of L-BMAA would imply an increase of the synthesis of GSK3β and a slight decrease of the inactive form of the enzyme. Therefore in response to L-BMAA treatment, GSK3β is possibly translocated to the nucleus, contributing to the process of cell death. With regard to the increase of nuclear GSK3α reported herein, it has been described that an accumulation of nuclear GSK3α mediates some neurological disorders including AD (AzoulayAlfaguter et al., 2011) . Therefore, it is tentative to speculate that GSK3α plays a role in the cellular death caused by L-BMAA treatment.
On the other hand, we must point out that TDP-43 plays an important role in the pathogenesis of motor neuron diseases and frontotemporal lobar degeneration. This protein is a major component of the characteristic ubiquitinated neuronal inclusions, which are hallmarks of these pathologies (Lee et al., 2011) . The appearance of aberrant forms of TDP-43 has been associated with mutations in this protein (Liu-Yesucevitz et al., 2010) . In the past few years, it has been reported that L-BMAA is bound into proteins, due to it can be bound to serine transfer RNA and become part of the protein chain. This misincorporation of wrong proteinogenic aminoacid L-BMAA can lead to alterations in protein structures performing misfolded proteins in genetically susceptible individuals. In addition, neurons are extremely sensitive to misfolded proteins, possibly because these potencially toxic species cannot be diluted out of cell (Cox, 2009; Dunlop and Rodgers, 2011; Rodgers and Dunlop, 2011) . It is noteworthy that Pablo et al., (2009) have confirmed that protein-bound L-BMAA is present in the brains of patients with AD and ALS. Furthermore, the roles of environmental exposure and genetic predisposition in producing these diseases-related accumulation of L-BMAA have been reported (Vance et al., 2010) Our experiments indicate that neuroblastoma cells treated with L-BMAA present an increase in aberrant forms of TDP-43, similar to those found in the pathological TDP-43 aggregates, appearing in some neurodegenerative diseases. Therefore, it is tentative to speculate that these TDP-43 misfolded proteins could form aggregates related with neuronal injury. In addition, TDP-43 and other misfolded proteins could be ubiquitinated as a normal biological response to an aberrant protein modification.
In conclusion, this study demonstrates that L-BMAA produces cell death in human neuroblastoma and evokes alterations in GSK3β and TDP-43, two possible biomarkers of neurodegenerative diseases.
